Melanoma antigen preferentially expressed in tumors (301-309)
  1. Home
  2. Peptide
  3. Others
  4. Melanoma antigen preferentially expressed in tumors (301-309)
Need Assistance?
  • US & Canada:
    +
  • UK: +

Melanoma antigen preferentially expressed in tumors (301-309)

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Melanoma antigen preferentially expressed in tumors (301-309) is a bioactive peptide of Melanoma antigen preferentially expressed in tumors. Melanoma antigen preferentially expressed in tumors inhibits the signaling of retinoic acid through the retinoic acid receptors RARA, RARB and RARG as a transcriptional repressor.

Category
Others
Catalog number
BAT-009683
Synonyms
Opa-interacting protein 4 (301-309); Preferentially expressed antigen of melanoma (301-309)
Sequence
LYVDSLFFL
Storage
Common storage 2-8°C, long time storage -20°C.
Related Products
Melanostatin DM
Melanostatin DM

CAT NO. : BAT-006230
Azido-PEG4-alcohol
Azido-PEG4-alcohol

CAT NO. : BAT-001233
N-acetyl semax
N-acetyl semax

CAT NO. : BAT-009137
N-acetyl Selank
N-acetyl Selank

CAT NO. : BAT-009138
Myristoyl tripeptide-31
Myristoyl tripeptide-31

CAT NO. : BAT-006235
Octapeptide-2
Octapeptide-2

CAT NO. : BAT-006229
Online Inquiry
Verification code
Inquiry Basket
Loading ......
Delete selectedGo to checkout